Notice Type
Departmental
Notice Title

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Tysabri
Active Ingredient: Natalizumab 20mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Biogen Idec NZ Limited
Manufacturers: Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Teva Parenteral Medicines Inc, Irvine, California, United States of America
Hospira Inc, McPherson, Kansas, United States of America
Dated this 6th day of November 2009.
STUART POWELL, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).